NTRA earnings call for the period ending June 30, 2019.
News & Analysis: Natera
Investors are excited about two new products for the genetic testing and liquid biopsy developer.
NTRA earnings call for the period ending March 31, 2019.
The genetic testing leader announced full-year 2018 operating results, but the numbers were actually pretty poor.
NTRA earnings call for the period ending December 31, 2018.
Here's why these stocks are making moves in after-hours trading.
Here's what's pushing up the top-performing, non-pharmaceutical healthcare stocks.
Shares jump in response to two bullish analyst notes. Here's what investors need to know.
The non-invasive genetic screening company tests are gaining popularity.
Shares fall hard in response to the release of a less than stellar earnings report.